Population frequency of germline BRCA1/2 mutations

Journal of Clinical Oncology

Volumn 34, Issue 34, 2016, Pages 4183-4185

  Maxwell, Kara N ^a   Domchek, Susan M ^a   Nathanson, Katherine L ^a   Robson, Mark E ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN, HUMAN;

ALLELE; CANCER RISK; GENE SEQUENCE; GENETIC RISK; GERMLINE MUTATION; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HUMAN; LETTER; MALE BREAST CANCER; MISSENSE MUTATION; POPULATION GENETICS; PRIORITY JOURNAL; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; MALE; MUTATION RATE; NEOPLASM; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS;

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; MALE; MUTATION RATE; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84995916502     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.67.0554     Document Type: Letter

References (11)

1. Daly MB, Pilarski R, Axilbund JE, et al: Genetic/familial high-risk assessment: Breast and ovarian, version 1.2014. J Natl Compr Canc Netw 12:1326-1338, 2014
2. Mavaddat N, Peock S, Frost D, et al: Cancer risks for BRCA1 and BRCA2 mutation carriers: Results from prospective analysis of EMBRACE. J Natl Cancer Inst 105:812-822, 2013
3. Schrader KA, Cheng DT, Joseph V, et al: Germline variants in targeted tumor sequencing using matched normal DNA. JAMA Oncol 2:104-111, 2016
4. Erratum Schrader KA, Cheng DT, Joseph V, et al: Germline variants in targeted tumor sequencing using matched normal DNA. JAMA Oncol 2:279, 2016
5. Gabai-Kapara E, Lahad A, Kaufman B, et al: Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. Proc Natl Acad Sci USA 111:14205-14210, 2014
6. King MC, Levy-Lahad E, Lahad A: Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award. JAMA 312:1091-1092, 2014
7. Anglian Breast Cancer Study Group: Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83:1301-1308, 2000
8. Thompson ER, Rowley SM, Li N, et al: Panel testing for familial breast cancer: Calibrating the tension between research and clinical care. J Clin Oncol 34: 1455-1459, 2016
9. National Heart, Lung, and Blood Institute: NHLBI exome sequencing project (ESP): Exome variant server. http://evs.gs.washington.edu/EVS/
10. Exome Aggregation Consortium: ExAC browser (beta). http://exac.broadinstitute.org
11. Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA): The Netherlands. https://enigmaconsortium.org/wp-content/uploads/2016/06/ENIGMA-Rules-2015-03-26.pdf